FLORA GROWTH CORP. Aktie

Flora Growth’s stock plunged about 28.4% in after-hours trading after the company announced a guaranteed public offering of only new common shares. R.F. Lafferty & Co. is acting as bookrunner, and the offering is to be made under an already filed S-3 shelf registration. Flora Growth also announced a rename to ZeroStack and said it will in future describe itself as an asset manager focused on decentralized AI. Investors reacted with concerns about dilution; the timing and terms of the issuance remain dependent on market conditions. » More on de.investing.com

Flora Growth has announced a placed public offering of its common stock, with R.F. Lafferty & Co. as sole book-running manager. All shares offered are to come from the company’s existing holdings; size and price range were not disclosed. The offering is subject to market conditions and will be made pursuant to a previously filed shelf registration (Form S-3). Flora Growth plans to change its name to ZeroStack and, according to InvestingPro, has more liquid assets than debt but has recently seen dwindling cash reserves and revenue growth while still not yet profitable. » More on de.investing.com

Flora Growth reported a loss per share of $9.05 for the quarter ended September 30, 2025 (prior year: -$10.92). Revenue fell to $9.8 million, down 21.81% from $12.5 million in the same quarter a year earlier. » More on finanzen.net

Flora Growth filed a blog post as Exhibit 99.1 to an 8‑K with the SEC, noting that the full content was not included in the filing and that it contains forward‑looking statements that cite risks such as volatility in cryptocurrency holdings, share price movements, regulatory requirements and access to capital. The company filed a prospectus supplement for an at‑the‑market offering of $3.45 million and continued selling shares under a previously completed prospectus. Flora Growth also announced a planned name change/private placement related to DeFi Development/ZeroStack and reported the death of independent director Harold Wolkin, which temporarily affected Nasdaq governance requirements; the minimum price requirement has since been met. In addition, the company carried out a 1‑for‑39 reverse split and trading was adjusted accordingly. » More on de.investing.com

Flora Growth has filed a prospectus supplement for an at-the-market offering with Revere Securities that permits the sale of common stock worth up to $3.45 million. The supplement is related to the S-3 registration; a prior ATM supplement was terminated after sales totaling $129,482. The company reports high cash burn and a 47% stock decline year-to-date. Flora Growth has since regained compliance with the NASDAQ minimum price requirement following a 1:39 reverse split; there was also a board change and planned transactions with DeFi Development/ZeroStack including a contribution in kind of Solana for a convertible note. » More on de.investing.com